5 Key Takeaways
-
1
Minimally invasive glaucoma surgeries (MIGS) effectively lower intraocular pressure (IOP) in Black patients with advanced glaucoma.
-
2
A study analyzed IRIS registry data from over 18,000 eyes, primarily focusing on patients who had cataract surgery.
-
3
Among MIGS procedures, the Omni device required fewer medications at 36 months compared to Hydrus and iStent inject.
-
4
Cataract surgery alone in glaucoma patients led to elevated IOP over time, highlighting missed treatment opportunities.
-
5
MIGS should be considered for all patients, including African-American individuals undergoing cataract surgery.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







